M&A Deal Summary

Integer Acquires BIOMEC

On March 19, 2007, Integer acquired medical products company BIOMEC for 11M USD

Acquisition Highlights
  • This is Integer’s 1st transaction in the Medical Products sector.
  • This is Integer’s 9th largest (disclosed) transaction.
  • This is Integer’s 3rd transaction in the United States.
  • This is Integer’s 1st transaction in Ohio.

M&A Deal Summary
Date 2007-03-19
Target BIOMEC
Sector Medical Products
Buyer(s) Integer
Deal Type Add-on Acquisition
Deal Value 11M USD

Target

BIOMEC

Cleveland, Ohio, United States
BIOMEC Inc. was established with the objective of accelerating promising technology from major medical and academic institutions, national laboratories, and internal proprietary developments to successful commercial products. BIOMEC operates in Cleveland, OH and has built a highly effective engineering team with diverse capabilities in medical device development that provides creative solutions for customer's product development needs.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Integer

Plano, Texas, United States
Category Company
Founded 1970
Sector Medical Products
Employees10,500
Revenue 1.6B USD (2023)
DESCRIPTION

Integer is a medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, orthopedics, vascular, advanced surgical and power solutions markets. Integer was founded in 1970 and is based in Plano, Texas.

DEAL STATS #
Overall 3 of 13
Sector (Medical Products) 1 of 11
Type (Add-on Acquisition) 3 of 13
State (Ohio) 1 of 1
Country (United States) 3 of 10
Year (2007) 1 of 4
Size (of disclosed) 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-03-16 NanoGram Devices

Fremont, California, United States

NDC is a materials research and development company focused on developing nanoscale materials for use in various battery and medical device applications.

Buy $45M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-06 Enpath Medical

Minneapolis, Minnesota, United States

Enpath Medical, Inc. is a leader in the design, development, manufacture and marketing of percutaneous delivery systems and stimulation leads technologies. Its proprietary products include venous vessel introducers, articulating and fixed curve delivery catheters, epicardial and endocardial stimulation leads, and other products for use in pacemaker, defibrillator, catheter and infusion port procedures as well as neuromodulation markets.

Buy -
Mergr

Product

Company

Legal